Gene · 6595
Papers3,459
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,459
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dedifferentiated/undifferentiated endometrial carcinoma:SWI/SNF-deficiency and molecular heterogeneity indicating novel prognostic stratification in a single-center study of 71 cases. | Hum Pathol | 2026 | 42162929 | PubTator, text mining | PubMed |
| Identification and comprehensive analysis of gene characteristics related to chromatin remodeling in thyroid cancer patients. | Medicine (Baltimore) | 2026 | 42152354 | PubTator, text mining | PubMed |
| Antibody-Mediated Delivery of BRM/BRG1 Protein Degraders Affords Strong Antitumor Efficacy in Multiple BRM-Dependent Non-Small Cell Lung Cancer Xenograft Models. | J Med Chem | 2026 | 42144767 | PubTator, text mining | PubMed |
| A Case of Incidentally Followed Thoracic SMARCA4-Deficient Undifferentiated Tumor: Insights Into the Tumor Origin. | Pathol Int | 2026 | 42124357 | PubTator, text mining | PubMed |
| Selective ARID1A Loss Restricted to the Undifferentiated Component of a Mismatch Repair-Deficient Gastric Carcinoma: A Case Report. | Case Rep Gastrointest Med | 2026 | 42094876 | PubTator, text mining | PubMed |
| Genome-wide association study of myopia progression in Chinese adolescents and application of polygenic risk score prediction. | Front Chem | 2026 | 42094695 | PubTator, text mining | PubMed |
| Illustrating the "Quiet Genome" Concept of SMARCA4 -Deficient Uterine Sarcoma Via Whole-Exome Sequencing: A Highly Aggressive Case in a Young Woman. | Int J Gynecol Pathol | 2026 | 42091066 | PubTator, text mining | PubMed |
| N‑Iminopyridinium Ylides as Chemically Stable Pharmacophores Enabling Targeted Degradation of SMARCA Proteins. | JACS Au | 2026 | 42063845 | PubTator, text mining | PubMed |
| GWAS meta-analysis of cerebrospinal fluid Alzheimer's biomarkers reveals loci regulating lipids, brain volume and autophagy. | Nat Commun | 2026 | 42014397 | PubTator, text mining | PubMed |
| Case Report: Whole genome sequencing of small cell ovarian carcinomas. | Front Oncol | 2026 | 41988129 | PubTator, text mining | PubMed |
| The computational analysis of tumor cell sensitivity to supertarget deletion. | Vavilovskii Zhurnal Genet Selektsii | 2026 | 41971655 | PubTator, text mining | PubMed |
| Epigenetic Activity of Cancer Therapy Drugs Revealed by HeLa TI Cell-Based Assay. | Epigenomes | 2026 | 41892363 | PubTator, text mining | PubMed |
| Development and validation of a highly accurate multigene gene expression biomarker to predict chemotherapy response in primary triple-negative breast cancer. | Breast Cancer Res Treat | 2026 | 41885969 | PubTator, text mining | PubMed |
| Quantitative DIA-MS Uncovers Functional Impact of SMARCA4 Knockdown in Group 3 Medulloblastoma. | J Proteome Res | 2026 | 41885501 | PubTator, text mining | PubMed |
| p63 in skin homeostasis and disease: molecular mechanisms and therapeutic potentials. | Cell Death Discov | 2026 | 41876478 | PubTator, text mining | PubMed |
| The Science of Rod-Mediated Dark Adaptation, an Outcome Measure for Age-Related Macular Degeneration: The 2025 Proctor Medal Lecture. | Invest Ophthalmol Vis Sci | 2026 | 41837573 | PubTator, text mining | PubMed |
| First-Line Treatment of Advanced Thoracic SMARCA4-Deficient Undifferentiated Tumor: A Case Report and Review of the Literature. | Case Rep Oncol Med | 2026 | 41809723 | PubTator, text mining | PubMed |
| SMARCA4/2 loss reduces BCL-xL expression and confers a druggable MCL1 dependency in cancer. | NPJ Precis Oncol | 2026 | 41807550 | PubTator, text mining | PubMed |
| The dual role of BRD9 in cancer: Mechanistic insights and therapeutic prospects. | iScience | 2026 | 41797932 | PubTator, text mining | PubMed |
| SWI/SNF-associated molecular subtypes reshape tumor microenvironmental features and inform precision therapeutic strategies in bladder cancer. | Front Cell Infect Microbiol | 2026 | 41789425 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6595/papers?page=2